...
首页> 外文期刊>Ocular immunology and inflammation >Comparison of presenting features and three-year disease course in Turkish patients with Beh?et uveitis who presented in the early 1990s and the early 2000s
【24h】

Comparison of presenting features and three-year disease course in Turkish patients with Beh?et uveitis who presented in the early 1990s and the early 2000s

机译:1990年代初和2000年代初出现的土耳其Beh?et葡萄膜炎患者的表现特征和三年病程的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To compare Beh?et uveitis patients who presented in the 1990s and 2000s. Methods: Records of 170 patients seen in 1990-1994 and 258 patients seen in 2000-2004 were reviewed. Presenting features were analyzed in the whole cohort. Uveitis attacks, vision, complications, and immunomodulatory treatment (IMT) were compared in patients with 3-year follow-up. Results: Posterior segment involvement was less common, visual acuity was better, and more patients received IMT before referral in the 2000s. Follow-up revealed no significant difference in number of uveitis attacks in the first 3 years. Less eyes lost useful vision, no patient became legally blind, and fewer severe ocular complications occurred in the 2000s. IMT was started within 3 months in more patients and interferon alfa-2a was used only in the latter study period. Conclusions: The findings suggest a milder disease at referral, lower rate of severe complications, and a better 3-year visual outcome in patients who presented in the early 2000s.
机译:目的:比较1990年代和2000年代出现的Beh?et葡萄膜炎患者。方法:回顾性分析1990-1994年间170例患者和2000-2004年间258例患者的记录。在整个队列中分析了呈现特征。对3年随访的患者进行了葡萄膜炎发作,视力,并发症和免疫调节治疗(IMT)的比较。结果:在2000年代,后段受累较少见,视力更好,并且有更多患者接受IMT治疗。随访显示,前3年葡萄膜炎发作次数无明显差异。在2000年代,更少的眼睛失去了有用的视力,没有患者成为合法盲人,更少的严重眼部并发症。 IMT在3个月内开始在更多患者中使用,干扰素alfa-2a仅在后期研究期间使用。结论:研究结果表明,在2000年代初就诊的患者转诊时病情较轻,严重并发症的发生率较低,并且3年视觉效果更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号